Precision science to advance protein engineering for immune resilience and longevity.

We are building a platform of engineered protein therapeutics by decoding cellular signaling with genomics, automation, and machine learning. Founded on breakthrough work from our scientific co‑founder, Prof. Elena Vasquez at Stanford, and driven by a world-class group of researchers, we are redefining how living systems can be designed and directed.

Our findings have been repeatedly published in Science, Science Immunology, Cell Systems, and PNAS, underscoring the depth of our platform.

Today, our focus is immune-driven disease, while our long-term ambition reaches further: to fundamentally reprogram how the body defends itself.